C5a promotes migration, proliferation, and vessel formation in endothelial cells

Inflammation Research

Volumn 59, Issue 8, 2010, Pages 659-666

  Kurihara, Ryuji ^a   Yamaoka, Kunihiro ^a   Sawamukai, Norifumi ^a   Shimajiri, Shohei ^a   Oshita, Koichi ^a   Yukawa, Sonosuke ^a   Tokunaga, Mikiko ^a   Iwata, Shigeru ^a   Saito, Kazuyoshi ^a   Chiba, Kenji ^b   Tanaka, Yoshiya ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

Activated complement; Angiogenesis; C5a; Endothelial cell; Inflammatory diseases

Indexed keywords

ANTIINFLAMMATORY AGENT; COLLAGEN TYPE 1; COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG; W 54011;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; DRUG MECHANISM; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MALE; MICROVASCULATURE; MORPHOGENESIS; MOUSE; NONHUMAN; PROTEIN FUNCTION; PROTEIN TARGETING; SKIN CAPILLARY; VASCULAR ENDOTHELIUM; VENULE;

ANIMALS; CELL CYCLE; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; COMPLEMENT ACTIVATION; COMPLEMENT C5A; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 77955658951     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-010-0178-4     Document Type: Article

References (36)

1. RF Guo PA Ward 2005 Role of C5a in inflammatory responses Annu Rev Immunol 23 821 852 10.1146/annurev.immunol.23.021704.115835 1:CAS:528: DC%2BD2MXktFOju7s%3D 15771587
2. RA Swerlick KB Yancey TJ Lawley 1989 Inflammatory properties of human C5a and C5a des Arg/in mast cell-depleted human skin J Invest Dermatol 93 417 422 10.1111/1523-1747.ep12280306 1:CAS:528:DyaL1MXlsFWlu74%3D 2527912
3. KE Foreman AA Vaporciyan BK Bonish ML Jones KJ Johnson MM Glovsky, et al. 1994 C5a-induced expression of P-selectin in endothelial cells J Clin Invest 94 1147 1155 10.1172/JCI117430 1:CAS:528:DyaK2cXmtVeitL8%3D 7521884
4. M Watanabe Y Fujioka-Kaneko H Kobayashi M Kiniwa M Kuwano Y Basaki 2005 Involvement of integrin-linked kinase in capillary/tube-like network formation of human vascular endothelial cells Biol Proced Online 7 41 47 10.1251/bpo104 1:CAS:528:DC%2BD2MXls1Gjs7Y%3D 16136223
5. J Hirosumi Y Ouchi M Watanabe J Kusunoki T Nakamura H Orimo 1989 Effects of growth factors on cytosolic free calcium concentration and DNA synthesis in cultured rat aortic smooth muscle cells Tohoku J Exp Med 157 289 300 10.1620/tjem.157.289 1:CAS:528:DyaL1MXksFWitbY%3D 2741168
6. D Sakurai N Tsuchiya A Yamaguchi Y Okaji NH Tsuno T Kobata, et al. 2004 Crucial role of inhibitor of DNA binding/differentiation in the vascular endothelial growth factor-induced activation and angiogenic processes of human endothelial cells J Immunol 173 5801 5809 1:CAS:528:DC%2BD2cXos1Ghsb4%3D 15494533
7. D Shepro NM Morel 1993 Pericyte physiology FASEB J 7 1031 1038 1:CAS:528:DyaK2cXltlel 8370472
8. T Oikawa M Sasaki M Inose M Shimamura H Kuboki S Hirano, et al. 1997 Effects of cytogenin, a novel microbial product, on embryonic and tumor cell-induced angiogenic responses in vivo Anticancer Res 17 1881 1886 1:CAS:528:DyaK2sXkvFymur8%3D 9216639
9. T Monsinjon P Gasque P Chan A Ischenko JJ Brady MC Fontaine 2003 Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells FASEB J 17 1003 1014 10.1096/fj.02- 0737com 1:CAS:528:DC%2BD3sXktl2gtbs%3D 12773483
10. IU Schraufstatter K Trieu L Sikora P Sriramarao R DiScipio 2002 Complement C3a and C5a induce different signal transduction cascades in endothelial cells J Immunol 169 2102 2110 1:CAS:528:DC%2BD38XmtFejtrg%3D 12165538
11. IJ Laudes JC Chu M Huber-Lang RF Guo NC Riedemann JV Sarma F Mahdi, et al. 2002 Expression and function of C5a receptor in mouse microvascular endothelial cells J Immunol 169 5962 5970 1:CAS:528:DC%2BD38Xosl2isrc%3D 12421982
12. PN Monk A-M Scola P Madala DP Fairlie 2007 Function, structure and therapeutic potential of complement C5a receptors Br J Pharmacol 152 429 448 10.1038/sj.bjp.0707332 1:CAS:528:DC%2BD2sXhtFKiur3F 17603557
13. H Sumichika K Sakata N Sato S Takeshita S Ishibuchi M Nakamura, et al. 2002 Identification of a potent and orally active non-peptide C5a receptor antagonist J Biol Chem 277 49403 49407 10.1074/jbc.M209672200 1:CAS:528:DC%2BD38XpsFaksrY%3D 12384495
14. H Sumichika 2004 C5a receptor antagonists for the treatment of inflammation Curr Opin Investig Drugs 5 505 510 1:CAS:528:DC%2BD2cXnt1Srsbc%3D 15202723
15. I Farkas L Baranyi ZS Liposits T Yamamoto H Okada 1998 Complement C5a anaphylatoxin fragment causes apoptosis in TGW neuroblastoma cells Neuroscience 86 903 911 10.1016/S0306-4522(98)00108-0 1:CAS:528:DyaK1cXksVWksL8%3D 9692726
16. NC Riedemann RF Guo TA Neff IJ Laudes KA Keller VJ Sarma, et al. 2002 Increased C5a receptor expression in sepsis J Clin Invest 110 101 108 1:CAS:528:DC%2BD38XltF2rurw%3D 12093893
17. SR Barnum 2002 Complement in central nervous system inflammation Immunol Res 26 7 13 10.1385/IR:26:1-3:007 1:CAS:528:DC%2BD38Xos1Cju7k%3D 12403340
18. S Nataf PF Stahel N Davoust SR Barnum 1999 Complement anaphylatoxin receptors on neurons: new tricks for old receptors? Trends Neurosci 22 397 402 10.1016/S0166-2236(98)01390-3 1:CAS:528:DyaK1MXlsVygtrY%3D 10441300
19. SR Barnum RS Ames PR Maycox SJ Hadingham J Meakin D Harrison, et al. 2002 Expression of the complement C3a and C5a receptors after permanent focal ischemia: an alternative interpretation Glia 38 169 173 10.1002/glia.10069 11948810
20. NC Riedemann RF Guo TJ Hollmann H Gao TA Neff JS Reuben, et al. 2004 Regulatory role of C5a in LPS-induced IL-6 production by neutrophils during sepsis FASEB J 18 370 372 1:CAS:528:DC%2BD2cXht1Gjt7k%3D 14688199
21. D Rittirsch MA Flierl BA Nadeau DE Day M Huber-Lang CR Mackay, et al. 2008 Functional roles for C5a receptors in sepsis Nat Med 14 551 557 10.1038/nm1753 1:CAS:528:DC%2BD1cXlsFCms74%3D 18454156
22. PJ Jose IK Moss RN Maini TJ Williams 1990 Measurement of the chemotactic complement fragment C5a in rheumatoid synovial fluids by radioimmunoassay: role of C5a in the acute inflammatory phase Ann Rheum Dis 49 747 752 10.1136/ard.49.10.747 1:CAS:528:DyaK3MXmtVSmtA%3D%3D 2241262
23. EP Grant D Picarella T Burwell T Delaney A Croci N Avitahl, et al. 2002 Essential role for the C5a receptor in regulating the effector phase of synovial infiltration and joint destruction in experimental arthritis J Exp Med 196 1461 1471 10.1084/jem.20020205 1:CAS:528:DC%2BD38XpsVahtL0%3D 12461081
24. A Denk M Goebeler S Schmid I Berberich O Ritz D Lindemann, et al. 2001 Activation of NF-κB via the IκB kinase complex is both essential and sufficient for proinflammatory gene expression in primary endothelial cells J Biol Chem 276 28451 28458 10.1074/jbc.M102698200 1:CAS:528:DC%2BD3MXls1SrtLw%3D 11337506
25. HP Kiener M Baghestanian M Dominkus S Walchshofer M Ghannadan M Willheim, et al. 1998 Expression of the C5a receptor (CD88) on synovial mast cells in patients with rheumatoid arthritis Arthritis Rheum 41 233 245 10.1002/1529-0131(199802)41:2<233::AID-ART7>3.0.CO;2-V 1:STN:280:DyaK1c7ktlKitw%3D%3D 9485081
26. Paleolog EM. Angiogenesis in rheumatoid arthritis. Arthritis Rev. 2002;S81-90.
27. Y Wang SA Rollins JA Madri LA Matis 1995 Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease Proc Natl Acad Sci USA 92 8955 8959 10.1073/pnas.92.19.8955 1:CAS:528: DyaK2MXotVGqt7w%3D 7568051
28. I Vermes C Haanen H Steffens-Nakken C Reutelingsperger 1995 A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V J Immunol Methods 184 39 51 10.1016/0022-1759(95)00072-I 1:CAS:528:DyaK2MXnt1Ojsbo%3D 7622868
29. X Lin K Takahashi SL Campion Y Liu GG Gustavsen LA Pena, et al. 2006 Synthetic peptide F2A4-K-NS mimics fibroblast growth factor-2 in vitro and is angiogenic in vivo Int J Mol Med 17 833 839 1:CAS:528:DC%2BD28Xks1Cht7s%3D 16596268
30. SM Stieger SH Bloch O Foreman ER Wisner KW Ferrara PA Davton 2006 Ultrasound assessment of angiogenesis in a Matrigel model in rats Ultrasound Med Biol 32 673 681 10.1016/j.ultrasmedbio.2005.12.008 16677927
31. R Tamarat JS Silvestre M Durie BI Lew 2002 AngiotensinII angiogenic effect in vivo involves vascular endothelial growth factor and inflammation related pathways Lab Invest 82 747 756 1:CAS:528:DC%2BD38Xls1eju74%3D 12065685
32. I Barkefors S Le Jan L Jakobsson E Hejll G Carlson H Johansson, et al. 2008 Endothelial cell migration in stable gradients of vascular endothelial growth factor A and fibroblast growth factor 2: effects on chemotaxis and chemokinesis J Biol Chem 283 13905 13912 10.1074/jbc.M704917200 1:CAS:528:DC%2BD1cXls12lsL4%3D 18347025
33. EA Albrecht AM Chinnaiyan S Varambally C Kumar-Sinha TR Barrette JV Sarma, et al. 2004 C5a-induced gene expression in human umbilical vein endothelial cells Am J Pathol 164 849 859 1:CAS:528:DC%2BD2cXitl2jtro%3D 14982839
34. K Hartmann BM Henz S Krüger-Krasagakes J Köhl R Burger S Guhl, et al. 1997 C3a and C5a stimulate chemotaxis of human mast cells Blood 89 2863 2870 1:CAS:528:DyaK2sXisFChs7k%3D 9108406
35. W Falk EJ Leonard 1980 Human monocyte chemotaxis: migrating cells are a subpopulation with multiple chemotaxin specificities on each cell Infect Immun 29 953 959 1:CAS:528:DyaL3cXmtVamsbs%3D 7429640
36. N Kawaguchi K Toriyama E Nicodemou-Lena K Inou S Torii Y Kitagawa 1998 De novo adipogenesis in mice at the site of injection of basement membrane and basic fibroblast growth factor Proc Natl Acad Sci USA 95 1062 1066 10.1073/pnas.95.3.1062 1:CAS:528:DyaK1cXosFSltQ%3D%3D 9448285